All the news Showing 10 of 63 articles from: FranceGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Harm reduction interventions and policy Living With Drugs: France approves safe injection rooms for users International Business Times / 10 April 2015 Finance, funding & health economics France uses tax to put pressure on hepatitis C drug prices Reuters / 01 October 2014 Genotype 4 AbbVie 2-drug combination + ribavirin achieves 100% cure in previously untreated genotype 4 hepatitis C Keith Alcorn / 22 April 2014 A combination of two direct-acting antivirals developed by AbbVie cured 100% of previously untreated patients with hepatitis C genotype 4 infection when used with ribavirin, Christophe Hézode reported on Friday at the ... Transmission and prevention Treatment for prevention for hepatitis C in French drug users could cut HCV prevalence by two-thirds in 10 years Keith Alcorn / 12 April 2014 A combination of increased testing, improved linkage to care and treatment immediately after diagnosis with interferon-free regimens has the potential to substantially reduce the incidence and prevalence of hepatitis C virus ... Nucleotide Ns5B polymerase inhibitors Idenix files suit in Europe against rival Gilead Boston Globe / 17 March 2014 Treatment in liver transplanted Patients with recurrent HCV benefit from triple therapy after liver transplant Healio Hepatology / 17 September 2013 Compassionate access Sign-on letter to Gilead about sofosbuvir TRT-5 / 29 July 2013 Treatment for people living with HIV and HCV People with HIV/HCV co-infection can do well on hepatitis C triple therapy despite contraindications Liz Highleyman / 24 July 2013 Nearly three-quarters of people with HIV and hepatitis C (HCV) co-infection in the French HEPAVIH cohort achieved end-of-treatment virological response to hepatitis C treatment with telaprevir plus pegylated interferon/ribavirin, even though one-third had ... Access to medicines & diagnostics Hepatitis C treatment gap in Europe: France doing well but Italy treated fewer than one in a hundred patients in 2010 Caspar Thomson / 23 May 2013 France led the world in the proportion of its hepatitis C patients who received treatment in 2010, but some countries in southern and eastern Europe had treatment rates that were almost tenfold ... Triple therapy Triple-drug HCV therapy comes with high risk of serious adverse events for people with cirrhosis Keith Alcorn / 30 April 2013 Currently available triple therapies for hepatitis C carry a high risk of serious side-effects for people in the most urgent need of treatment, and these patients have only a moderate chance of being ... ← Prev1...34567Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive